Cargando…

Ovarian Cancer

Detalles Bibliográficos
Autores principales:	Song, Yong Sang, Kim, Hee Seung, Aoki, Daisuke, Dhanasekaran, Danny N., Tsang, Benjamin K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283453/ https://www.ncbi.nlm.nih.gov/pubmed/25587539 http://dx.doi.org/10.1155/2014/764323

Ejemplares similares

Adipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 Pathway
por: Kim, Boyun, et al.
Publicado: (2017)

Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro
por: Kim, Soochi, et al.
Publicado: (2016)

Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer
por: Kim, Soochi, et al.
Publicado: (2018)

GNAi2/gip2-Regulated Transcriptome and Its Therapeutic Significance in Ovarian Cancer
por: Ha, Ji Hee, et al.
Publicado: (2021)

Identification of GNA12-driven gene signatures and key signaling networks in ovarian cancer
por: Ha, Ji-Hee, et al.
Publicado: (2021)

PGC1α induced by reactive oxygen species contributes to chemoresistance of ovarian cancer cells
por: Kim, Boyun, et al.
Publicado: (2017)

Metagenomic Analysis of Serum Microbe-Derived Extracellular Vesicles and Diagnostic Models to Differentiate Ovarian Cancer and Benign Ovarian Tumor
por: Kim, Se Ik, et al.
Publicado: (2020)

The second annual conference of International ovarian cancer consortium and the symposium on tumor microenvironment and therapeutic resistance
por: Isidoro, Ciro, et al.
Publicado: (2016)

Differential effects of thymoquinone on lysophosphatidic acid-induced oncogenic pathways in ovarian cancer cells
por: Ha, Ji Hee, et al.
Publicado: (2020)

Unraveling Autocrine Signaling Pathways through Metabolic Fingerprinting in Serous Ovarian Cancer Cells
por: Ha, Ji Hee, et al.
Publicado: (2021)

Current status and future directions of ovarian cancer prognostic models
por: Kobayashi, Yusuke, et al.
Publicado: (2021)

An open access journal of molecular signaling: a critical need at a critical time
por: Dhanasekaran, Danny N
Publicado: (2006)

Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus
por: Ha, Ji Hee, et al.
Publicado: (2016)

ROS-Induced SIRT2 Upregulation Contributes to Cisplatin Sensitivity in Ovarian Cancer
por: Wang, Wenyu, et al.
Publicado: (2020)

Aberrant expression of JNK-associated leucine-zipper protein, JLP, promotes accelerated growth of ovarian cancer
por: Ha, Ji Hee, et al.
Publicado: (2016)

The mTORC2 Component Rictor Contributes to Cisplatin Resistance in Human Ovarian Cancer Cells
por: Im-aram, Akechai, et al.
Publicado: (2013)

Recent advances in the biomarkers for epithelial ovarian cancer
por: Kim, Yun Hwan, et al.
Publicado: (2011)

Determinant role for the gep oncogenes, Gα12/13, in ovarian cancer cell proliferation and xenograft tumor growth
por: Ha, Ji Hee, et al.
Publicado: (2015)

Genistein as a Potential Anticancer Agent against Ovarian Cancer
por: Lee, Jung-Yun, et al.
Publicado: (2012)

Hax-1 is required for Rac1-Cortactin interaction and ovarian carcinoma cell migration
por: Gomathinayagam, Rohini, et al.
Publicado: (2014)

Tumor evolution and chemoresistance in ovarian cancer
por: Kim, Soochi, et al.
Publicado: (2018)

Targeting Oncometabolites in Peritoneal Cancers: Preclinical Insights and Therapeutic Strategies
por: Nadhan, Revathy, et al.
Publicado: (2023)

How Autophagy Shapes the Tumor Microenvironment in Ovarian Cancer
por: Ferraresi, Alessandra, et al.
Publicado: (2020)

Protective Effect of Progesterone during Pregnancy against Ovarian Cancer
por: Han, Kyung Hee, et al.
Publicado: (2013)

Glycolysis Inhibition of Autophagy Drives Malignancy in Ovarian Cancer: Exacerbation by IL-6 and Attenuation by Resveratrol
por: Vidoni, Chiara, et al.
Publicado: (2023)

Laparoscopic surgery for early ovarian cancer
por: Aoki, Daisuke
Publicado: (2014)

Signaling by LncRNAs: Structure, Cellular Homeostasis, and Disease Pathology
por: Nadhan, Revathy, et al.
Publicado: (2022)

Resveratrol as a Tumor-Suppressive Nutraceutical Modulating Tumor Microenvironment and Malignant Behaviors of Cancer
por: Han, Youngjin, et al.
Publicado: (2019)

Chemopreventive and Anticancer Effects of Thymoquinone: Cellular and Molecular Targets
por: Gomathinayagam, Rohini, et al.
Publicado: (2020)

Ovarian Cancer Biomarker Discovery Based on Genomic Approaches
por: Lee, Jung-Yun, et al.
Publicado: (2013)

Modulation of non-coding RNAs by resveratrol in ovarian cancer cells: In silico analysis and literature review of the anti-cancer pathways involved
por: Vallino, Letizia, et al.
Publicado: (2020)

BECN1 and BRCA1 Deficiency Sensitizes Ovarian Cancer to Platinum Therapy and Confers Better Prognosis
por: Salwa, Amreen, et al.
Publicado: (2021)

Elevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysis
por: Luo, Yanlin, et al.
Publicado: (2017)

Epigenetic Therapies as a Promising Strategy for Overcoming Chemoresistance in Epithelial Ovarian Cancer
por: Suh, Dong Hoon, et al.
Publicado: (2013)

Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer
por: Luo, Yanlin, et al.
Publicado: (2016)

Role of cystathionine beta synthase in lipid metabolism in ovarian cancer
por: Chakraborty, Prabir K., et al.
Publicado: (2015)

SERPINB3 in the Chicken Model of Ovarian Cancer: A Prognostic Factor for Platinum Resistance and Survival in Patients with Epithelial Ovarian Cancer
por: Lim, Whasun, et al.
Publicado: (2012)

How to make the best strategy to manage thromboembolism in ovarian cancer?
por: Lim, Myong Cheol, et al.
Publicado: (2012)

How to start niraparib in real-world Asian ovarian cancer patients?
por: Hong, Sook-Hee
Publicado: (2021)

Correction: SERPINB3 in the Chicken Model of Ovarian Cancer: A Prognostic Factor for Platinum Resistance and Survival in Patients with Epithelial Ovarian Cancer
por: Lim, Whasun, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_j0274cpk7ov53uqugr0ds7op4k